Growth Metrics

Biogen (BIIB) Receivables - Net (2016 - 2025)

Biogen (BIIB) has 17 years of Receivables - Net data on record, last reported at $1.3 billion in Q4 2025.

  • For Q4 2025, Receivables - Net fell 4.44% year-over-year to $1.3 billion; the TTM value through Dec 2025 reached $1.3 billion, down 4.44%, while the annual FY2025 figure was $1.3 billion, 4.44% down from the prior year.
  • Receivables - Net reached $1.3 billion in Q4 2025 per BIIB's latest filing, up from $4.8 million in the prior quarter.
  • Across five years, Receivables - Net topped out at $1.9 billion in Q1 2021 and bottomed at $3.9 million in Q1 2025.
  • Average Receivables - Net over 5 years is $1.1 billion, with a median of $1.6 billion recorded in 2021.
  • Peak YoY movement for Receivables - Net: tumbled 99.55% in 2023, then soared 8448.42% in 2025.
  • A 5-year view of Receivables - Net shows it stood at $1.5 billion in 2021, then increased by 10.04% to $1.7 billion in 2022, then dropped by 2.4% to $1.7 billion in 2023, then dropped by 15.58% to $1.4 billion in 2024, then dropped by 4.44% to $1.3 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Receivables - Net were $1.3 billion in Q4 2025, $4.8 million in Q3 2025, and $1.6 billion in Q2 2025.